恶性黑色素瘤的化疗 - Suppr

Suppr

超能文献

Chemotherapy of malignant melanoma.

作者信息

Benjamin R S

出版信息

World J Surg. 1979 Jul 30;3(3):321-8. doi: 10.1007/BF01556584.

DOI:10.1007/BF01556584

PMID:382646

Abstract

摘要

相似文献

Chemotherapy of malignant melanoma.

World J Surg. 1979 Jul 30;3(3):321-8. doi: 10.1007/BF01556584.

[Fotemustine in the treatment of metastatic malignant melanoma. Overall analysis of results].

Pathol Biol (Paris). 1990 Oct;38(8):876-80.

DTIC (NSC-45388) in malignant melanoma: a perspective.

Cancer Treat Rep. 1976 Feb;60(2):165-76.

Single drug and combination chemotherapy in the treatment. Disseminated malignant melanoma.

Minn Med. 1977 Aug;60(8):543-8.

Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma.

Cancer Treat Rev. 1974 Dec;1(4):285-304. doi: 10.1016/s0305-7372(74)80020-4.

Adjuvant chemoimmunotherapy stage I/II malignant melanoma.

J Surg Oncol. 1982 Mar;19(3):165-70. doi: 10.1002/jso.2930190311.

[Chemotherapy of malignant melanoma].

Chirurg. 1986 Oct;57(10):606-11.

Chemotherapy of melanoma.

Semin Oncol. 1975 Jun;2(2):179-85.

[Chemotherapy of malignant melanomas].

Haematol Blood Transfus. 1978;21:293-302.

Chemotherapy of unresectable or recurrent metastatic malignant melanomas: an update.

J Dermatol Surg Oncol. 1979 Feb;5(2):118-23. doi: 10.1111/j.1524-4725.1979.tb00624.x.

引用本文的文献

The evolution in melanoma treatment as a reflection of precision-oriented medicine.

Oncol Lett. 2013 Feb;5(2):424-426. doi: 10.3892/ol.2012.1065. Epub 2012 Dec 5.

Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma.

Invest New Drugs. 1987;5(3):293-7. doi: 10.1007/BF00175301.

本文引用的文献

Intermittent treatment of metastatic malignant melanoma with high-dose 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).

Cancer Chemother Rep. 1971 Apr;55(2):175-81.

Prognostic correlations and response to treatment in advanced metastatic malignant melanoma.

Cancer Res. 1974 Aug;34(8):1995-2004.

Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma.

Cancer Treat Rev. 1974 Dec;1(4):285-304. doi: 10.1016/s0305-7372(74)80020-4.

Chemotherapy of malignant melanoma.

Cancer. 1972 Dec;30(6):1604-15. doi: 10.1002/1097-0142(197212)30:6<1604::aid-cncr2820300629>3.0.co;2-5.

[Treatment of metastasising melanoma with a combination of cytostatic agents (author's transl)].

Dtsch Med Wochenschr. 1976 Jun 4;101(23):890-4. doi: 10.1055/s-0028-1104136.

A pharmacokinetically based phase I-II study of single-dose actinomycin D (NSC-3053).

Cancer Treat Rep. 1976 Mar;60(3):289-91.

A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.

Med Pediatr Oncol. 1975;1(2):107-11. doi: 10.1002/mpo.2950010205.

Comparison of the combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-1-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanoma.

Cancer. 1975 Feb;35(2):368-71. doi: 10.1002/1097-0142(197502)35:2<368::aid-cncr2820350211>3.0.co;2-c.

Combination chemotherapy for disseminated malignant melanoma.

Cancer. 1975 Feb;35(2):342-6. doi: 10.1002/1097-0142(197502)35:2<342::aid-cncr2820350207>3.0.co;2-f.

Treatment of malignant melanoma with vinblastine (NSC-49842), procarbazine (NSC-77213), and actinomycin D (NSC-3053).

Cancer Chemother Rep. 1975 Jul-Aug;59(4):767-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验